Washington: New research suggests that treatment with the cholesterol drug simvastatin significantly reduces lung damage resulting from severe abdominal sepsis and infection."We hope that this study will not only provide new knowledge about the complicated pathophysiology behind abdominal sepsis, but also form the basis for more effective and specific treatment options for patients with severe infections," said Henrik Thorlacius, a researcher involved in the workfrom the Department of Surgery at Skane University Hospital at Lund University, Malmo, Sweden.
The study was recently published in the Journal of Leukocyte Biology. ANI
Appointment of IPS Archana challenged; hearing in SC tomorrow
Railway recruitment board paper leaked in Lucknow, two held
Pune blast: ATS to question Indian Mujahideen terrorists in custody
UPSC aspirants protest outside Rajnath Singh`s residence